We are live on ! Find out more
PAHC icon

Phibro Animal Health

174 hedge funds and large institutions have $902M invested in Phibro Animal Health in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 56 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 18

16% more capital invested

Capital invested by funds: $776M → $902M (+$126M)

13% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 56

2% more funds holding

Funds holding: 171174 (+3)

0.87% less ownership

Funds ownership: 99.82%98.96% (-0.87%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
174
Holders Change
+3
Holders Change %
+1.75%
% of All Funds
3.98%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
23
Increased
63
Reduced
56
Closed
18
Calls
Puts
Net Calls
Net Calls Change

PAHC Hedge Fund Activity: Q2 2018 in Review

174 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2018, worth a combined $902M — up 16% from $776M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new PAHC positions and 18 closed out — a net gain of 5 holders — while 63 added to existing stakes and 56 trimmed.

The largest buyer was Segall Bryant & Hamill, opening a new position worth an estimated $20.9M. The largest seller was Foresters Investment Management, cutting an estimated $12.9M.

  • 174 institutional investors held Phibro Animal Health (PAHC) as of Q2 2018, up from 171 in Q1 2018.
  • Funds reported $902M of Phibro Animal Health stock for Q2 2018, up 16% quarter-over-quarter.
  • 23 funds opened new Phibro Animal Health positions in Q2 2018 and 18 closed out, a net change of +5 holders.
  • The largest Phibro Animal Health buyer in Q2 2018 was Segall Bryant & Hamill, an estimated $20.9M added.
  • The largest Phibro Animal Health seller in Q2 2018 was Foresters Investment Management, an estimated $12.9M sold.

Based on aggregated 13F filings for Q2 2018.